BamSEC and AlphaSense Join Forces
Learn More

Targanta Therapeutics Corp.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.25
from 10-Q 72 pages Attachments
12/34/56
EX-10.14.1
from 10-K 3 pages [*] = Certain Material (Indicated by an Asterisk) Has Been Omitted From This Document Pursuant to a Request for Confidential Treatment. the Omitted Material Has Been Filed Separately With the Securities and Exchange Commission. First Amendment to Manufacturing Services Agreement
12/34/56
EX-10.11.2
from 10-K 2 pages Second Amendment to Lease
12/34/56
EX-10.8
from 10-K 10 pages Employment Agreement
12/34/56
EX-10.7
from 10-K 8 pages 1. Start Date; Part-Time Employment 1.1 This Agreement Become Effective on August 10, 2006, the Start Date. This Agreement Will Continue Until Terminated Pursuant to Article VII. 1.2 the Executive Shall Not Work Less Than 40 Hours Per Week. 1.3 the Corporation Shall Employ the Executive Full Time. 1.4 the Executive Shall Perform His Duties Principally at the Corporation’s Facilities in Indianapolis, Indiana
12/34/56
EX-10.21
from S-1/A 16 pages Targanta Therapeutics Corporation Warrant to Subscribe for Series B Preferred Stock Introduction
12/34/56
EX-10.2.4
from S-1/A 3 pages - 1 - Restricted Stock Award Agreement for Company Officers and Directors Under the Targanta Therapeutics Corporation 2007 Stock Option and Incentive Plan
12/34/56
EX-10.2.3
from S-1/A 4 pages Non-Qualified Stock Option Agreement for Non-Employee Directors Under the Targanta Therapeutics Corporation 2007 Stock Option and Incentive Plan
12/34/56
EX-10.2.2
from S-1/A 5 pages Non-Qualified Stock Option Agreement for Company Officers Under the Targanta Therapeutics Corporation 2007 Stock Option and Incentive Plan
12/34/56
EX-10.2.1
from S-1/A 5 pages Incentive Stock Option Agreement for Company Officers Under the Targanta Therapeutics Corporation 2007 Stock Option and Incentive Plan
12/34/56
EX-10.2
from S-1/A 19 pages Targanta Therapeutics Corporation 2007 Stock Option and Incentive Plan
12/34/56
EX-10.5.1
from S-1/A 3 pages Amendment No. 1 to Employment Agreement
12/34/56
EX-10.16.4
from S-1/A 7 pages Amendment Number 4 to the Development and Supply Agreement Dated December 28, 2001 Between Abbott Laboratories and Intermune, Inc
12/34/56
EX-10.16.3
from S-1/A 3 pages Amendment Number 3 to Development and Supply Agreement Dated December 28, 2001 Between Abbott Laboratories and Intermune, Inc
12/34/56
EX-10.16.2
from S-1/A 4 pages Amendment Number 2
12/34/56
EX-10.16.1
from S-1/A 3 pages Amendment Number 1
12/34/56
EX-10.16
from S-1/A 30 pages [*] = Certain Material (Indicated by an Asterisk) Has Been Omitted From This Document Pursuant to a Request for Confidential Treatment. the Omitted Material Has Been Filed Separately With the Securities and Exchange Commission
12/34/56
EX-10.11
from S-1/A 34 pages License Agreement
12/34/56
EX-10.10
from S-1/A 21 pages Manufacturing Services Agreement
12/34/56
EX-10.9
from S-1/A 9 pages Office Sublease Agreement
12/34/56